|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133,700.00 KRW | -2.48% |
|
-1.91% | +26.49% |
| 05-27 | HEALTH ROUNDS-Veracyte genomic test identifies breast cancer patients who can skip chemo | RE |
| 05-15 | ORION Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 5,285B 3.53B 3.1B 2.88B 2.65B 4.99B 338B 5.11B 34.31B 13.43B 166B 13.25B 12.96B 575B | P/E 2026 * |
11x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 3.82B 2.55M 2.24M 2.08M 1.91M 3.61M 244M 3.69M 24.81M 9.71M 120M 9.58M 9.37M 416M | EV / Sales 2026 * |
1.03x | EV / Sales 2027 * | 0.9x |
| Free-Float |
56.15% | Yield 2026 * |
2.96% | Yield 2027 * | 3.12% |
| 1 day | -2.48% | ||
| 1 week | -1.91% | ||
| Current month | +1.36% | ||
| 1 month | -1.33% | ||
| 3 months | +0.98% | ||
| 6 months | +25.54% | ||
| Current year | +26.49% |
| 1 week | 130,400 |  | 143,200 |
| 1 month | 120,300 | | 145,300 |
| Current year | 102,000 | | 150,100 |
| 1 year | 99,000 | | 150,100 |
| 3 years | 81,800 | | 150,100 |
| 5 years | 80,200 | | 150,100 |
| 10 years | 75,700 | | 164,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seung-Joon Lee
CEO | Chief Executive Officer | 66 | 31/12/2021 |
Cheol-Gon Tam
PRN | Corporate Officer/Principal | 71 | 01/04/1980 |
| Director | Title | Age | Since |
|---|---|---|---|
In-Cheol Heo
BRD | Director/Board Member | 66 | 30/06/2014 |
Wook Lee
BRD | Director/Board Member | 67 | 29/02/2020 |
Seung-Joon Lee
CHM | Chairman | 66 | 31/12/1993 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/01/25 | Others | 17 | 0.0000% | |||
| 19/05/24 | Others | 342 | 0.0009% | |||
| 19/05/24 | Others | 4,474 | 0.0113% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | -1.91% | +10.77% | +11.70% | 3.61B | |
| +1.20% | -0.46% | +9.31% | -19.62% | 265B | |
| +1.75% | -1.72% | -10.90% | -16.16% | 75.52B | |
| -0.30% | -1.63% | +6.43% | +30.61% | 53B | |
| -1.54% | +2.10% | +134.47% | +480.53% | 43.01B | |
| +2.03% | +6.84% | +49.33% | +4.20% | 38.75B | |
| +0.91% | -3.79% | +6.36% | -26.62% | 35.23B | |
| -2.02% | -8.95% | +44.42% | +108.62% | 33.87B | |
| +1.53% | -0.55% | -7.04% | -29.45% | 29.47B | |
| -2.06% | -2.24% | +18.77% | +23.76% | 29.45B | |
| Average | -0.10% | -2.20% | +26.19% | +56.76% | 60.7B | |
| Weighted average by Cap. | +0.64% | -1.91% | +19.43% | +30.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3,700B 2.47B 2.17B 2.01B 1.85B 3.5B 236B 3.57B 24.02B 9.4B 116B 9.28B 9.08B 403B | 3,917B 2.62B 2.3B 2.13B 1.96B 3.7B 250B 3.78B 25.43B 9.95B 123B 9.82B 9.61B 426B |
| Net income | 479B 320M 281M 261M 240M 453M 30.59B 463M 3.11B 1.22B 15.02B 1.2B 1.17B 52.1B | 522B 349M 307M 284M 262M 494M 33.36B 504M 3.39B 1.33B 16.39B 1.31B 1.28B 56.81B |
| Net Debt | -1,464B -978M -859M -796M -733M -1.38B -93.51B -1.41B -9.5B -3.72B -45.93B -3.67B -3.59B -159B | -1,757B -1.17B -1.03B -956M -880M -1.66B -112B -1.7B -11.4B -4.46B -55.11B -4.4B -4.31B -191B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/07/26 | ₩133,700.00 | -2.48% | 128,707 |
| 10/07/26 | ₩137,100.00 | +1.18% | 141,543 |
| 09/07/26 | ₩135,500.00 | -3.42% | 102,559 |
| 08/07/26 | ₩140,300.00 | +0.57% | 141,119 |
| 07/07/26 | ₩139,500.00 | +1.90% | 130,966 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A271560 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
